Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-infected Individuals”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03254277
What this trial is testing

3BNC117-LS First-in-Human Phase 1 Study

Who this might be right for
Human Immunodeficiency Virus
Rockefeller University 43
Large-scale testing (Phase 3)WithdrawnNCT01605084
What this trial is testing

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Who this might be right for
HIV
Bristol-Myers Squibb
Post-approval studies (Phase 4)Ended earlyNCT00765154
What this trial is testing

NNRTI/PI Toxicity Switch to Darunavir Study

Who this might be right for
HIV
St Stephens Aids Trust 12
Not applicableUnknownNCT03913351
What this trial is testing

Lifestyle Modification Programme for HIV-infected Individuals With Fatty Liver

Who this might be right for
NAFLDHiv
Chinese University of Hong Kong 96
Post-approval studies (Phase 4)UnknownNCT04708496
What this trial is testing

Optimizing Malaria Treatment for HIV-Malaria Co-infected Individuals

Who this might be right for
HIV CoinfectionMalaria
Makerere University 888
Large-scale testing (Phase 3)Ended earlyNCT00147355
What this trial is testing

Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 Substudy

Who this might be right for
HIV Infections
Kirby Institute 28
Not applicableStudy completedNCT00000684
What this trial is testing

Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Early research (Phase 1)Study completedNCT00080431
What this trial is testing

Daclizumab to Treat HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT06940375
What this trial is testing

Incidence of Liver Disease-Related Outcomes in People With HIV

Who this might be right for
MAFLDLiver FibrosisMASH+3 more
Shanghai Public Health Clinical Center 315
Testing effectiveness (Phase 2)Study completedNCT00001034
What this trial is testing

The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV

Who this might be right for
Cytomegalovirus RetinitisHIV InfectionsGastrointestinal Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 850
Large-scale testing (Phase 3)Study completedNCT00183781
What this trial is testing

Effectiveness of a Telephone Intervention Program in Improving Depression, Coping, and Family Functioning in HIV-Infected Individuals and Caregivers

Who this might be right for
HIV Infections
Butler Hospital 270
Not applicableStudy completedNCT00000914
What this trial is testing

The Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 800
Early research (Phase 1)Study completedNCT02511990
What this trial is testing

The Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074

Who this might be right for
HealthyHIV
Rockefeller University 33
Testing effectiveness (Phase 2)Study completedNCT00819390
What this trial is testing

Chloroquine for Reducing Immune Activation in HIV- Infected Individuals

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 70
Testing effectiveness (Phase 2)Study completedNCT00405821
What this trial is testing

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

Who this might be right for
HIV InfectionsHerpes Genitalis
National Institute of Allergy and Infectious Diseases (NIAID) 440
Early research (Phase 1)Study completedNCT00000755
What this trial is testing

A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 168
Testing effectiveness (Phase 2)Study completedNCT00000918
What this trial is testing

Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Post-approval studies (Phase 4)Study completedNCT04904406
What this trial is testing

Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals

Who this might be right for
HivHIV InfectionsHIV Cardiomyopathy+3 more
Thomas Benfield 81
Not applicableStudy completedNCT03279523
What this trial is testing

F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected

Who this might be right for
Alzheimer DiseaseHIV
Tammie L. S. Benzinger, MD, PhD 60
Not applicableUnknownNCT05372510
What this trial is testing

Feasibility of Identifying, Enrolling and Following Acute and Early HIV-1 Infected Individuals.

Who this might be right for
Acute Human Immunodeficiency Virus Type I Infection
MRC/UVRI and LSHTM Uganda Research Unit 100
Next Page